Latest press releases from neurocare group AG
neurocare group has received approval to market its TMS devices in Saudi Arabia, marking a significant advancement in mental health...
NRx Pharmaceuticals and neurocare Group AG launch a nationwide program integrating TMS, medications, and psychotherapy to treat Depression,...
FDA clears neurocare group's Apollo TMS Therapy for adolescent depression, offering a safe, non-invasive alternative to traditional...
.jpg)
Leadership continuity positions neurocare for its next decade of global expansion, innovation, and patient impact.
Leadership continuity positions neurocare for its next decade of global expansion, innovation, and patient impact.
This acquisition expands neurocare’s clinic network to 11 locations in the Netherlands and marks a key step into care focused on pregnancy,...
Adds Five High-Performing Clinics to a Growing International Network
Adds Five High-Performing Clinics to a Growing International Network
neurocare group AG secures EUR 19.3 million investment to expand its innovative mental health platform globally, enhancing care through...
neurocare group is pleased to announce the appointment of Kevin Reeder as Chief Financial Officer of the company, from January 2025.
neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS)...
neurocare group expands mental health care reach through acquisition of Smart TMS clinics in the UK, offering innovative personalized...
neurocare group expands mental health care reach through acquisition of Smart TMS clinics in the UK, offering innovative personalized...
The appointment is part of neurocare's vision to expand its footprint in the MENA region, furthering the company's mission to create a...
The investment will enable the company to execute on its growth plans, including expansion into the MENA region.
Contact
Get in touch to learn more about innovations in mental health and performance
